A

Amydis Diagnostics, Inc.

9 employees

Amydis is a pharmaceutical company that focuses on developing innovative chemistry to detect diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

molecular diagnostics

Diagnostics

ALS

Pharmaceutical

Parkinson's Disease

imaging

digital biomarker

surrogate biomarker

eye

Health Diagnostics

Neuroscience

Cerebral amyloid angiopathy

retina

Alzheimer's Disease

Neurodegeneration

Amyloids

Ophthalmology

Date founded

2013

Funding rounds raised

Total raised

$3M

from 3 investors over 3 rounds

A

Amydis Diagnostics, Inc. raised $3M on October 11, 2021

Investors: National Institute of Neurological Disorders and Stroke (NINDS)

A

Amydis Diagnostics, Inc. raised undisclosed on September 2, 2021

Investors: National Institutes of Health

A

Amydis Diagnostics, Inc. raised undisclosed on September 26, 2018